These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 8403297
21. Comparative safety profiles of hirulog and heparin in patients undergoing coronary angioplasty. The Hirulog Angioplasty Study Investigators. Bittl JA. Am Heart J; 1995 Sep; 130(3 Pt 2):658-65. PubMed ID: 7668214 [Abstract] [Full Text] [Related]
22. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators. Bittl JA, Strony J, Brinker JA, Ahmed WH, Meckel CR, Chaitman BR, Maraganore J, Deutsch E, Adelman B. N Engl J Med; 1995 Sep 21; 333(12):764-9. PubMed ID: 7643883 [Abstract] [Full Text] [Related]
23. Hirudin and hirudin analogues as new anticoagulant agents. Pineo GF, Hull RD. Curr Opin Hematol; 1995 Sep 21; 2(5):380-5. PubMed ID: 9372023 [Abstract] [Full Text] [Related]
24. Antithrombotic effects of hirulog in a rat carotid endarterectomy model. Jackson MR, Reid TJ, Tang DB, O'Donnell SD, Gomez ER, Alving BM. J Surg Res; 1996 Jan 21; 60(1):15-22. PubMed ID: 8592407 [Abstract] [Full Text] [Related]
25. Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators. White HD, Aylward PE, Frey MJ, Adgey AA, Nair R, Hillis WS, Shalev Y, Brown MA, French JK, Collins R, Maraganore J, Adelman B. Circulation; 1997 Oct 07; 96(7):2155-61. PubMed ID: 9337184 [Abstract] [Full Text] [Related]
28. A pilot, early angiographic patency study using a direct thrombin inhibitor as adjunctive therapy to streptokinase in acute myocardial infarction. Lidón RM, Théroux P, Lespérance J, Adelman B, Bonan R, Duval D, Lévesque J. Circulation; 1994 Apr 07; 89(4):1567-72. PubMed ID: 8149522 [Abstract] [Full Text] [Related]
29. Hirudin: clinical potential of a thrombin inhibitor. Johnson PH. Annu Rev Med; 1994 Apr 07; 45():165-77. PubMed ID: 8198374 [Abstract] [Full Text] [Related]
34. Ecarin clotting time but not aPTT correlates with PEG-hirudin plasma activity. Moser M, Ruef J, Peter K, Kohler B, Gulba DC, Paterna N, Nordt T, Kübler W, Bode C. J Thromb Thrombolysis; 2001 Oct 07; 12(2):165-9. PubMed ID: 11729368 [Abstract] [Full Text] [Related]
39. Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) trial. Yusuf S. Am J Cardiol; 1999 Sep 02; 84(5A):20M-25M. PubMed ID: 10505539 [Abstract] [Full Text] [Related]